Huitema ADR - Search Results

1

Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.

van der Kleij MBA, Guchelaar NAD, Meertens M, Westerdijk K, Giraud EL, Bleckman RF, Groenland SL, van Eerden RAG, Imholz ALT, Vulink AJE, Otten HM, Fiebrich-Westra HB, Lubberman FJE, Desar IME, Moes DAR, Touw DJ, Koolen SLW, Gelderblom H, Reyners AKL, van Erp NP, Mathijssen RHJ, Huitema ADR; Dutch Pharmacology Oncology Group (DPOG); Steeghs N. van der Kleij MBA, et al. Among authors: huitema adr. Br J Cancer. 2024 Sep;131(5):843-851. doi: 10.1038/s41416-024-02789-2. Epub 2024 Jul 6. Br J Cancer. 2024. PMID: 38971952 Free PMC article.

2

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer.

Helgason HH, Kruijtzer CM, Huitema AD, Marcus SG, ten Bokkel Huinink WW, Schot ME, Schornagel JH, Beijnen JH, Schellens JH. Helgason HH, et al. Br J Cancer. 2006 Oct 9;95(7):794-800. doi: 10.1038/sj.bjc.6603332. Epub 2006 Sep 12. Br J Cancer. 2006. PMID: 16969354 Free PMC article. Clinical Trial.

3

A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours.

Siegel-Lakhai WS, Zandvliet AS, Huitema AD, Tibben MM, Milano G, Girre V, Diéras V, King A, Richmond E, Wanders J, Beijnen JH, Schellens JH. Siegel-Lakhai WS, et al. Br J Cancer. 2008 Apr 22;98(8):1320-6. doi: 10.1038/sj.bjc.6604300. Epub 2008 Apr 15. Br J Cancer. 2008. PMID: 18414469 Free PMC article.

4

Pharmacokinetics of gemcitabine and metabolites in a patient with double-sided nephrectomy: a case report and review of the literature.

Koolen SL, Huitema AD, Jansen RS, van Voorthuizen T, Beijnen JH, Smit WM, Schellens JH. Koolen SL, et al. Oncologist. 2009 Sep;14(9):944-8. doi: 10.1634/theoncologist.2009-0111. Epub 2009 Sep 2. Oncologist. 2009. PMID: 19726456 Free article. Review.

5

Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.

Koolen SL, Oostendorp RL, Beijnen JH, Schellens JH, Huitema AD. Koolen SL, et al. Br J Clin Pharmacol. 2010 May;69(5):465-74. doi: 10.1111/j.1365-2125.2010.03621.x. Br J Clin Pharmacol. 2010. PMID: 20573082 Free PMC article. Clinical Trial.

6

From mouse to man: predictions of human pharmacokinetics of orally administered docetaxel from preclinical studies.

Koolen SL, van Waterschoot RA, van Tellingen O, Schinkel AH, Beijnen JH, Schellens JH, Huitema AD. Koolen SL, et al. J Clin Pharmacol. 2012 Mar;52(3):370-80. doi: 10.1177/0091270010397051. Epub 2011 Apr 19. J Clin Pharmacol. 2012. PMID: 21505085

7

Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001).

Moes JJ, Koolen SL, Huitema AD, Schellens JH, Beijnen JH, Nuijen B. Moes JJ, et al. Int J Pharm. 2011 Nov 28;420(2):244-50. doi: 10.1016/j.ijpharm.2011.08.041. Epub 2011 Sep 2. Int J Pharm. 2011. PMID: 21907780 Clinical Trial.

8

Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.

Moes J, Koolen S, Huitema A, Schellens J, Beijnen J, Nuijen B. Moes J, et al. Eur J Pharm Biopharm. 2013 Jan;83(1):87-94. doi: 10.1016/j.ejpb.2012.09.016. Epub 2012 Oct 17. Eur J Pharm Biopharm. 2013. PMID: 23085332 Clinical Trial.

9

Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoring.

Lankheet NA, Steeghs N, Rosing H, Schellens JH, Beijnen JH, Huitema AD. Lankheet NA, et al. Ther Drug Monit. 2013 Apr;35(2):168-76. doi: 10.1097/FTD.0b013e31827efd9e. Ther Drug Monit. 2013. PMID: 23503442 Clinical Trial.

10

Phase II and pharmacological study of oral docetaxel plus cyclosporin A in anthracycline pre-treated metastatic breast cancer.

Helgason HH, Koolen SL, Werkhoven Ev, Malingre MM, Kruijtzer CM, Huitema AD, Schot ME, Smit WM, Beijnen JH, Schellens JH. Helgason HH, et al. Curr Clin Pharmacol. 2014 May;9(2):139-47. doi: 10.2174/1574884708666131111193403. Curr Clin Pharmacol. 2014. PMID: 24219005 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

508 results

Search Page

Filters